What is the recommended dosage and titration protocol for a continuous intravenous nicardipine infusion?

Nicardipine Continuous IV Infusion Dosing Protocol

Start nicardipine at 5 mg/hr and titrate by 2.5 mg/hr every 5-15 minutes to a maximum of 15 mg/hr until target blood pressure is achieved, then reduce to a maintenance dose of 3 mg/hr. 1

Initial Dosing

For gradual blood pressure reduction:

• Start at 5 mg/hr
• Increase by 2.5 mg/hr every 15 minutes until desired BP reduction is achieved
• Maximum dose: 15 mg/hr

For more rapid blood pressure reduction:

• Start at 5 mg/hr
• Increase by 2.5 mg/hr every 5 minutes until desired BP reduction is achieved
• Maximum dose: 15 mg/hr 1

Maintenance Dosing

Once target blood pressure is achieved:

• Reduce infusion rate to 3 mg/hr for maintenance 2
• Adjust rate as needed to maintain desired response 1

Context-Specific Protocols

Acute Ischemic Stroke (Pre-thrombolysis)

For patients eligible for rtPA with BP >185/110 mmHg:

• Start at 5 mg/hr
• Titrate up by 2.5 mg/hr at 5-15 minute intervals
• Maximum: 15 mg/hr
• Goal: Reduce and maintain BP <185/110 mmHg
• If goal not achieved, do not administer rtPA 3, 4, 3

Acute Ischemic Stroke (During/After thrombolysis)

For BP 180-230 mmHg systolic or 105-120 mmHg diastolic:

• Start at 5 mg/hr
• Titrate up by 2.5 mg/hr every 5 minutes
• Maximum: 15 mg/hr 3

For BP >230 mmHg systolic or 121-140 mmHg diastolic:

• Start at 5 mg/hr
• Titrate up by 2.5 mg/hr every 5 minutes
• Maximum: 15 mg/hr 3

Hypertensive Emergency (Non-stroke)

For systolic >220 mmHg or diastolic 121-140 mmHg:

• Start at 5 mg/hr
• Titrate by 2.5 mg/hr every 5 minutes
• Maximum: 15 mg/hr
• Target: 10-15% BP reduction 2, 5, 2

Pre-eclampsia/Eclampsia

• Start at 5 mg/hr
• Titrate by 2.5 mg/hr every 5-15 minutes
• Maximum: 15 mg/hr
• Safe and effective for severe pre-eclampsia 2, 6

Administration Details

Preparation:

• Dilute to concentration of 0.1 mg/mL (25 mg vial in 240 mL compatible fluid = 250 mL total) 1
• Premixed bags (0.1 or 0.2 mg/mL) do not require dilution 1

Compatible fluids:

• D5W, NS, D5W/0.45% NaCl, D5W/0.9% NaCl, D5W with 40 mEq K+
• NOT compatible with sodium bicarbonate 5% or Lactated Ringer's 1

Route:

• Administer via central line or large peripheral vein
• Change peripheral IV site every 12 hours to prevent phlebitis 1

Pharmacokinetics & Monitoring

Onset of action: 5-15 minutes 2

Time to effect:

• BP begins falling within minutes
• Reaches ~50% of ultimate decrease in 45 minutes 1

Offset after discontinuation:

• 50% offset in 30 minutes ± 7 minutes
• Plasma levels and gradual BP effects persist for hours 1

Monitoring:

• Blood pressure and heart rate continuously during titration
• After achieving target: every 15 min × 2 hrs, then every 30 min × 6 hrs, then hourly 3

Dose Adjustments for Hypotension/Tachycardia

If hypotension or tachycardia develops:

1. Discontinue infusion immediately
2. When BP and HR stabilize, restart at 3-5 mg/hr
3. Titrate carefully to maintain desired BP 1

Predictors of Required Dose

Higher doses typically needed in:

• Men (vs women)
• Younger patients (vs elderly)
• Higher initial systolic BP
• Higher body weight 7

Mean maximum dose in clinical practice: 9.1 ± 4.2 mg/hr 7

Important Caveats

Contraindications:

• Advanced liver failure 2

Common adverse effects:

• Headache and reflex tachycardia (most common) 2
• Phlebitis at infusion site (after ≥14 hours at single peripheral site) 8

Critical warning: Higher maximum doses (>9 mg/hr) were independently associated with early neurologic deterioration in ICH patients, though not with hematoma expansion or 3-month outcomes 7. This suggests careful titration to the minimum effective dose is prudent, particularly in hemorrhagic stroke.